Molecular radiotherapy - the radionuclide raffle?

被引：2
|
作者：
Gaze, M. N. [3 ]
Flux, G. D. [1 ,2 ]
机构：
[1] Royal Marsden NHS Fdn Trust, Joint Dept Phys, Sutton, Surrey, England
[2] Inst Canc Res, Sutton, Surrey, England
[3] Univ Coll London Hosp NHS Fdn Trust, Dept Oncol, London, England
来源：
BRITISH JOURNAL OF RADIOLOGY | 2010年 / 83卷 / 996期
关键词：
D O I：
10.1259/bjr/32706189
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
引用
收藏
页码：995 / 997
页数：3
相关论文
共 50 条
  • [31] Novel bio-carriers for radionuclide delivery in cancer radiotherapy
    Wang, Lishan
    He, Qing
    Man, Jianping
    Gao, Yechen
    Zhou, Guangming
    Si, Hongwei
    Yang, Kai
    Hu, Lin
    Pei, Pei
    COORDINATION CHEMISTRY REVIEWS, 2025, 533
  • [32] MEDICAL ASPECTS OF FITNESS TO DRIVE - RAFFLE,A
    不详
    COMMUNITY HEALTH, 1977, 9 (01): : 50 - 50
  • [33] An efficient proxy raffle protocol with anonymity-preserving
    Chang, Chin-Chen
    Cheng, Ting-Fang
    COMPUTER STANDARDS & INTERFACES, 2009, 31 (04) : 772 - 778
  • [34] 'IDIOT RAFFLE' + TRANSLATED BY GROSSMAN,EDITH
    ALVAREZGARDEAZABAL, G
    REVIEW-LATIN AMERICAN LITERATURE AND ARTS, 1976, (19): : 79 - 81
  • [35] AASV Foundation Auction and Mini raffle
    Burkgren, Tom
    Pettit, Jodie
    JOURNAL OF SWINE HEALTH AND PRODUCTION, 2016, 24 (03): : 183 - 183
  • [36] The future of radiotherapy is molecular
    Dale L. Bailey
    Wendy Philips
    Clive Baldock
    Physical and Engineering Sciences in Medicine, 2020, 43 : 755 - 759
  • [37] The future of radiotherapy is molecular
    Bailey, Dale L.
    Philips, Wendy
    Baldock, Clive
    PHYSICAL AND ENGINEERING SCIENCES IN MEDICINE, 2020, 43 (03) : 755 - 759
  • [38] Update on molecular radiotherapy
    Flux, G.
    RADIOTHERAPY AND ONCOLOGY, 2017, 123 : S299 - S299
  • [39] Pumpkin Pies and Public Goods: The Raffle Fundraising Strategy
    Brian Duncan
    Public Choice, 2002, 111 : 49 - 71
  • [40] The radionuclide molecular imaging and therapy of neuroendocrine tumors
    Li, SR
    Beheshti, M
    CURRENT CANCER DRUG TARGETS, 2005, 5 (02) : 139 - 148
12345